EUVIMEDAtrasti EUVIMED
Multizentrische StudieOpen access · CC BY 4.0

Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran‐Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly)

Marco Ceccanti iD, Pietro Guaraldi, Angela Romano iD, Giovanni Antonini, Alessandro Barilaro, Chiara Briani, Marco Burattini, Micol Gianoli, Giulia Carlini, Vittoria Cianci, Marco Currò Dossi, Daniela Di Lisi and 42 more

European Journal of Neurology · 2026-06 · 33 (6)

DOI: 10.1111/ene.70657 ↗

At a glance

Multizentrische Studie in European Journal of Neurology, published online on 2026-06-01. Written by Marco Ceccanti and 53 co-authors. Institution: Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy. Major MEDLINE topics: Amyloid Neuropathies, Familial, Prealbumin. Cited 1 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0).

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

The F64L variant is among the most frequent TTR mutations in Italy, typically associated with a predominantly neurologic phenotype and limited cardiac involvement.

Methods

Data from 181 ATTRv patients in the multicenter Patisiranitaly database treated with Patisiran since 2020 were analyzed. Neurologic impairment scores, Norfolk QoL‐DN, and cardiac parameters were compared between F64L ( n = 56), V30M ( n = 37), and non‐F64L ( n = 125) patients at baseline and during follow‐up. Cluster analysis was applied to identify patient subgroups based on these variables.

Results

F64L represented 30.9% of the cohort. Compared to non‐F64L patients, F64L patients had a higher prevalence of neurologic onset and neurologic phenotype, a thinner interventricular septum, and lower NT‐proBNP levels. Cluster analysis segregated patients into two distinct groups, predominantly reflecting F64L vs. non‐F64L status and corresponding neurologic severity. F64L patients showed milder cardiac involvement compared to V30M patients. Longitudinal repeated‐measures ANOVA showed stable clinical and instrumental measures.

Conclusions

F64L is characterized by predominant neurologic involvement and milder cardiac involvement in this Patisiran‐treated cohort. Mutation‐specific diagnostic and follow‐up strategies are essential to capture its natural history and treatment response.

Subjects

MeSH terms (MEDLINE)

Amyloid Neuropathies, FamilialPrealbuminHumansFemaleMalePhenotypeMutationMiddle AgedAgedCohort StudiesItalyRNA, Small Interfering

Author keywords

ATTRvF64L mutationNT‐proBNPp. phe84leutransthyretin amyloidosis

Substances

PrealbuminpatisiranTTR protein, humanRNA, Small Interfering

Authors and institutions

  • Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
  • IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
  • Dipartimento Di Neuroscienze, Organi Di Senso E Torace, UOC Neurologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli, 8, Rome, Italy.
  • Department of Neurology, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome and UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy.
  • AOU Careggi and Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.
  • Neurology Unit, Department of Neuroscience, University of Padua, Padua, Italy.

ORCID profiles: Marco Ceccanti, Angela Romano, Massimiliano Filosto, Luca Leonardi, Fiore Manganelli, Giammarco Milella, Davide Pareyson, Luca Guglielmo Pradotto, Matteo Tagliapietra, Francesca Vitali, Nicasio Rini, Roberto D'Angelo, Vincenzo Di Stefano

Cite

APA

Ceccanti, M., Guaraldi, P., Romano, A., Antonini, G., Barilaro, A., Briani, C., Burattini, M., Gianoli, M., Carlini, G., Cianci, V., Dossi, M. C., Di Lisi, D., Di Muzio, A., Ratti, A., Filosto, M., Gasverde, S., Gemelli, C., Gentile, L., Goglia, M., …, & Di Stefano, V. (2026). Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran‐Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly). European Journal of Neurology, 33(6). https://doi.org/10.1111/ene.70657

Vancouver

Ceccanti M, Guaraldi P, Romano A, Antonini G, Barilaro A, Briani C, et al. Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran‐Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly). European Journal of Neurology. 2026;33(6). doi:10.1111/ene.70657

BibTeX
@article{Ceccanti2026,
  author = {Ceccanti, Marco and Guaraldi, Pietro and Romano, Angela and Antonini, Giovanni and Barilaro, Alessandro and Briani, Chiara and Burattini, Marco and Gianoli, Micol and Carlini, Giulia and Cianci, Vittoria and Dossi, Marco Currò and Di Lisi, Daniela and Di Muzio, Antonio and Ratti, Adele and Filosto, Massimiliano and Gasverde, Sabrina and Gemelli, Chiara and Gentile, Luca and Goglia, Mariangela and Leonardi, Luca and Longhi, Simone and Lotti, Antonio and Manganelli, Fiore and Mazzeo, Anna and Augello, Sofia Maria and Milella, Giammarco and Novo, Giuseppina and Pareyson, Davide and Fenu, Silvia and Palumbo, Giovanni and Petrelli, Cristina and Poli, Loris and Pradotto, Luca Guglielmo and Russo, Massimo and Salvalaggio, Alessandro and Sciarrone, Maria Ausilia and Sellitti, Luigi and Tagliapietra, Matteo and Tozza, Stefano and Castiglia, Mariagiovanna and Turri, Mara and Verriello, Lorenzo and Chimenti, Cristina and Vitali, Francesca and Brighina, Filippo and Rini, Nicasio and Inghilleri, Maurizio and D'Angelo, Roberto and Abelardo, Domenico and Cambieri, Chiara and Libonati, Laura and Moret, Federica and Luigetti, Marco and Di Stefano, Vincenzo},
  title = {Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran‐Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly)},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {6},
  doi = {10.1111/ene.70657}
}
Start for free →